1 The effects in mice of administration of the anticonvulsants, progabide, sodium valproate, diazepam, carbamazepine and phenytoin on 5-hydroxytryptophan (5-HTP)-induced head-twitch, apomorphine-induced locomotion, clonidine-induced sedation, and P-adrenoceptor and 5-HT2 receptor number have been examined. 2 Repeated progabide administration (400 mg kg-', i.p. twice daily for 14 days) enhanced the headtwitch response the effect lasting for over 8 days after the last dose, and also increased 5-HT2 receptor number in frontal cortex. 3 Progabide (400 mg kg-', i.p.) enhanced the head-twitch response when given once daily for 10 days and when given intermittently (5 times over 10 days) but not after 1 day of administration. 4 Repeated Na valproate (400mg kg-',i.p.) also increased the 5-HTP-induced head-twitch response and 5-HT2 receptor number in the frontal cortex when given twice daily for 14 days, but no behavioural enhancement was seen after 10 days' treatment. 5 Diazepam (1.25 mg kg-', i.p.) twice daily for 14 days increased the head-twitch response and 5-HT2 receptor number. 6 Repeated progabide and valproate (but not diazepam) administration attenuated the sedation response to the a2-adrenoceptor agonist, clonidine (0.15mg kg-') but neither drug altered 1-adrenoceptor number in the cerebral cortex. 7 No changes in apomorphine-induced locomotor behaviour were seen after progabide, valproate or diazepam.8 Repeated carbamazepine (20 mg kg-') or phenytoin (40 mg kg-1) administration failed to alter any of the biochemical or behavioural parameters listed above. 9 Like repeated electroconvulsive shock (ECS), progabide altered the head-twitch response, clonidine-induced sedation response and 5-HT2 receptor number. Unlike repeated ECS, it did not alter P-adrenoceptor number or the apormorphine-induced locomotor response. These data suggest that ECS may produce some changes in monoamine function by altering GABA metabolism as has previously been postulated.